Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
GW468816 for Prevention of Relapse to Smoking
NCT00218465Phase 2Completed
- Sponsor
- Massachusetts General Hospital
- Start
- Aug 2006
- Primary completion
- Jun 2009
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of GW-468816 in nicotine dependence, sponsored by Massachusetts General Hospital. Started Aug 2006; status: completed.
02
Drugs
GW-468816
03
Conditions
nicotine dependence
Beyond the preview
Go deeper on NCT00218465.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00218465.